General Notes
This product (Catalog No. DPABH-02148) is a rabbit-derived polyclonal antibody raised against human PLAT, targeting the amino acid region 36–126 of the protein. This antibody exhibits cross-reactivity with Human PLAT from mouse and rat. It has been affinity purified by Protein A. Tenecteplase is a recombinant tissue plasminogen activator (tPA) and thrombolytic agent engineered for rapid intravenous administration to dissolve blood clots in acute thrombotic conditions. It is a bioengineered variant of alteplase with enhanced fibrin specificity, resistance to plasminogen activator inhibitor-1 (PAI-1), and a prolonged half-life (initial phase 20–24 minutes; terminal phase 90–130 minutes), enabling single-bolus dosing over 5 seconds. Developed using recombinant DNA technology in Chinese hamster ovary cells, tenecteplase catalyzes the conversion of plasminogen to plasmin, preferentially targeting fibrin-bound clots to restore blood flow while minimizing systemic fibrinogen depletion.
DPABH-02148 is suitable for use in ELISA (1:4,000–1:8,000), IHC (1:50–1:100), Western blot (WB) (1:1,000–1:4,000) applications.
DPABH-02148 is supplied as a liquid formulation in 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
COA
Publication 
Loading ......
